Search for Clinical Trial Results

Dysentery, Bacillary - 25 Studies Found
Status | Study |
Withdrawn |
Study Name: Shigella Sonnei OSPC-rDT Conjugate Vaccine Condition: Shigellosis Date: 2011-07-20 Interventions: Drug: CP Immunization |
Completed |
Study Name: Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3 Condition: Shigella Infection Date: 2011-04-14 Interventions:
|
Completed |
Study Name: A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults. Condition: Shigellosis Date: 2013-12-17 Interventions:
|
Completed |
Study Name: Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults Condition: Shigellosis Date: 2014-01-02 Interventions:
|
Completed |
Study Name: Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP Condition: Shigella Date: 2011-10-26 Interventions:
|
Terminated |
Study Name: Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb Condition: Shigella Date: 2009-03-19 Interventions: Biological: CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a The challenge strain consists |
Terminated |
Study Name: Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa Condition: Shigella Date: 2009-03-19 Interventions:
|
Completed |
Study Name: Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults Condition: Shigellosis Date: 2012-01-05 Interventions:
|
Completed |
Study Name: Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a Condition: Shigellosis Date: 2015-02-23 Interventions:
|
Completed |
Study Name: Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel Condition: Shigellosis Date: 2006-08-22 Interventions: Biological: Shigella conjugate vaccines Shigella sonnei-rEPA and Shigella flexneri2a rEPA vaccines |